Table 2.

Difference from placebo in QTc at T_max for maraviroc and moxifloxacin

		Adjusted means
End-point	Comparison	n	Active	Placebo	Mean diff.	90% CI
Machine-read QTcF at median Tmax	Maraviroc 100 mg vs. placebo	59	381.5	382.5	−0.93	(−2.8–0.98)
	Maraviroc 300 mg vs. placebo	58	381.1	382.4	−1.3	(−3.9–1.4)
	Maraviroc 900 mg vs. placebo	58	383.6	380.0	3.6	(1.5–5.8)
	Moxifloxacin 400 mg vs. placebo	58	393.4	379.7	13.7	(11.5–15.8)
Manually read QTcI at median Tmax	Maraviroc 100 mg vs. placebo	59	399.7	400.4	−0.72	(−3.0–1.6)
	Maraviroc 300 mg vs. placebo	58	400.8	400.6	0.24	(−1.9–2.3)
	Maraviroc 900 mg vs. placebo	58	402.8	399.2	3.6	(1.0–6.2)
	Moxifloxacin 400 mg vs. placebo	58	412.7	398.7	14.0	(11.5–16.4)